With a steady stream of breakthroughs in our understanding of and treatments for neurological diseases, there has never been...
Month: June 2023
“Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man.” Francisco Lopera, et al. – University of Antioquia,...
On June 15th, MS researchXchange held our second Live event, featuring Jessica Allanach and Dr. Marc Horwitz of the...
“Syndecan-1 as specific cerebrospinal fluid biomarker of multiple sclerosis.” Geoffrey Hinsinger, et al. – Université de Montpellier. To find...
“Integrated multimodal cell atlas of Alzheimer’s disease.” Mariano I. Gabitto, et al. – Allen Institute for Brain Science. To...
“Causal evidence that herpes zoster vaccination prevents a proportion of dementia cases.” Markus Eyting, et al. – Stanford University....
“A Predictive Autoantibody Signature in Multiple Sclerosis.” Colin R. Zamecnik, et al. – UCSF Weill Institute for Neurosciences To...
“Short-term surrogate biomarkers of chronic lesion expansion.” Samuel Klistorner, et al. – University of Sydney To enable predictions of...
“Targeting the TCA cycle can ameliorate widespread axonal energy deficiency in neuroinflammatory lesions.” Yi-Heng Tai, et al. – Ludwig-Maximilians...
Implication of DNA methylation changes at chromosome 1q21.1 in the brain pathology of Primary Progressive Multiple Sclerosis. Majid Pahlevan...